Beta Bionics (BBNX) Earnings Analysis

Beta Bionics (BBNX) next reports earnings on 2026-07-29, consensus EPS -0.62 USD. Last quarter (2026-04-21) it beat with EPS -0.49 USD vs -0.53 USD est (+7.5%). It has beaten estimates in 2/2 recent quarters (100%). Trailing P/E -10.80.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does BBNX next report earnings?

Next earnings date2026-07-29
Consensus EPS estimate-0.62 USD
Revenue estimate0.03B

BBNX earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-21-0.49 USD-0.53 USD+7.5%Beat
2026-02-17-0.3 USD-0.42 USD+28.6%Beat
2025-01-31-1.55424 USDn/an/an/a

Beat rate: 2/2 (100%) over reported quarters with consensus data.

BBNX valuation and analyst view

Trailing P/E-10.80
Trailing EPS-1.49515 USD
Price / book2.67
Dividend yield0.00%
Market cap0.74B
Analyst consensusBuy (6 buy / 2 hold / 0 sell)
Avg price target19.33 USD

Related research pages

Frequently asked questions

When is Beta Bionics (BBNX)'s next earnings date?

Beta Bionics is next scheduled to report on 2026-07-29, with a consensus EPS estimate of -0.62 USD and revenue estimate of 0.03B.

Did BBNX beat earnings last quarter?

In its 2026-04-21 report, BBNX posted EPS of -0.49 USD versus a -0.53 USD estimate — a beat of 7.5%.

What is BBNX's earnings track record?

Over the last 2 reported quarters with consensus data, BBNX beat estimates 2 times (100%).

What is BBNX's current P/E ratio and EPS?

BBNX trades at a trailing P/E of -10.80 on trailing EPS of -1.4951523613343458 USD.

What do analysts rate BBNX?

Analyst consensus is "Buy" across 8 ratings (0 strong buy, 6 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 19.33 USD.